Cribstone Capital Management’s Boston Scientific BSX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
$7.08K Hold
153
﹤0.01% 281
2022
Q3
$6K Sell
153
-207
-58% -$8.3K ﹤0.01% 285
2022
Q2
$13K Buy
360
+107
+42% +$4.36K 0.01% 240
2022
Q1
$11K Hold
253
0.01% 261
2021
Q4
$11K Hold
253
0.01% 261
2021
Q3
$11K Hold
253
0.01% 247
2021
Q2
$11K Hold
253
0.01% 256
2021
Q1
$10K Hold
253
0.01% 247
2020
Q4
$9K Hold
253
0.01% 249
2020
Q3
$10K Hold
253
0.01% 201
2020
Q2
$9K Hold
253
0.01% 221
2020
Q1
$8K Sell
253
-55
-18% -$2.15K 0.01% 221
2019
Q4
$14K Sell
308
-30
-9% -$1.25K 0.01% 235
2019
Q3
$14K Sell
338
-116
-26% -$4.92K 0.01% 378
2019
Q2
$20K Hold
454
0.01% 356
2019
Q1
$17K Buy
454
+30
+7% +$1.15K 0.01% 386
2018
Q4
$15K Hold
424
0.01% 406
2018
Q3
$16K Hold
424
0.01% 434
2018
Q2
$14K Hold
424
0.01% 454
2018
Q1
$12K Buy
424
+116
+38% +$3.15K 0.01% 472
2017
Q4
$8K Hold
308
﹤0.01% 598
2017
Q3
$9K Hold
308
﹤0.01% 514
2017
Q2
$9K Hold
308
﹤0.01% 503
2017
Q1
$8K Hold
308
﹤0.01% 547
2016
Q4
$7K Hold
308
﹤0.01% 538
2016
Q3
$7K Hold
308
﹤0.01% 540
2016
Q2
$7K Buy
+308
New +$6.66K ﹤0.01% 568

Other funds holding BSX

Cribstone Capital Management's BSX Position: Q4 2022 in Review

Cribstone Capital Management held its Boston Scientific (BSX) position steady in Q4 2022 at 153 shares worth $7.08K. The position accounts for ﹤0.01% of the portfolio, ranked #281.

Cribstone Capital Management first reported a position in BSX in Q2 2016 and has held it in 27 quarters since. The position peaked at $20K in Q2 2019. 928 funds tracked by Wall St. Rank hold BSX as of Q4 2022.

  • Cribstone Capital Management held 153 shares of Boston Scientific worth $7.08K as of Q4 2022.
  • Cribstone Capital Management left its Boston Scientific share count unchanged in Q4 2022.
  • Boston Scientific made up ﹤0.01% of Cribstone Capital Management's portfolio in Q4 2022, its #281 holding.
  • Cribstone Capital Management first reported a position in Boston Scientific in Q2 2016 and has held it in 27 quarters since.
  • Cribstone Capital Management's Boston Scientific position peaked at $20K in Q2 2019.
  • 928 funds tracked by Wall St. Rank held Boston Scientific as of Q4 2022.

Based on Cribstone Capital Management's 13F filing for Q4 2022, filed 14 Feb 2023.